Reporting owner · Q3 2026 · CIK 1231589

Mahon Paul A: insider trades.

Mahon Paul A reported 59 non-derivative transactions on 6 SEC ownership filings in Q3 2026: 0 open-market purchases and 52 sales ($25.8M), across 1 company.

Transactions
59
Purchases (P)
0
Sales (S)
52
Companies
1
Name as filed
MAHON PAUL A

Companies

CompanyRelationshipTransactions
UNITED THERAPEUTICS Corp (UTHR)Officer · EVP & GENERAL COUNSEL59

Transactions

59 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-09-17UNITED THERAPEUTICS CorpM8,300$146.0353,472Form 4
2026-09-17UNITED THERAPEUTICS CorpS1,579$495.9751,893Form 4
2026-09-17UNITED THERAPEUTICS CorpS2,873$496.5849,020Form 4
2026-09-17UNITED THERAPEUTICS CorpS1,400$497.5447,620Form 4
2026-09-17UNITED THERAPEUTICS CorpS843$498.7446,777Form 4
2026-09-17UNITED THERAPEUTICS CorpS1,160$499.7545,617Form 4
2026-09-17UNITED THERAPEUTICS CorpS125$500.845,492Form 4
2026-09-17UNITED THERAPEUTICS CorpS320$501.5845,172Form 4
2026-09-03UNITED THERAPEUTICS CorpS954$485.1246,269Form 4
2026-09-03UNITED THERAPEUTICS CorpS1,048$481.9247,583Form 4
2026-09-03UNITED THERAPEUTICS CorpS2,360$480.8648,631Form 4
2026-09-03UNITED THERAPEUTICS CorpS936$479.6650,991Form 4
2026-09-03UNITED THERAPEUTICS CorpS1,545$478.9351,927Form 4
2026-09-03UNITED THERAPEUTICS CorpM8,300$146.0353,472Form 4
2026-09-03UNITED THERAPEUTICS CorpS320$490.8945,172Form 4
2026-09-03UNITED THERAPEUTICS CorpS10$488.3245,492Form 4
2026-09-03UNITED THERAPEUTICS CorpS169$487.3645,502Form 4
2026-09-03UNITED THERAPEUTICS CorpS200$483.8547,223Form 4
2026-09-03UNITED THERAPEUTICS CorpS160$482.6647,423Form 4
2026-09-03UNITED THERAPEUTICS CorpS598$486.4745,671Form 4
2026-08-20UNITED THERAPEUTICS CorpS120$527.2145,172Form 4
2026-08-20UNITED THERAPEUTICS CorpS400$526.3945,292Form 4
2026-08-20UNITED THERAPEUTICS CorpS940$525.2545,692Form 4
2026-08-20UNITED THERAPEUTICS CorpS192$523.6946,632Form 4
2026-08-20UNITED THERAPEUTICS CorpS850$522.7846,824Form 4
2026-08-20UNITED THERAPEUTICS CorpS787$52247,674Form 4
2026-08-20UNITED THERAPEUTICS CorpS1,819$521.0448,461Form 4
2026-08-20UNITED THERAPEUTICS CorpS502$520.0350,280Form 4
2026-08-20UNITED THERAPEUTICS CorpS2,690$524.1550,782Form 4
2026-08-20UNITED THERAPEUTICS CorpM2,690$146.0347,862Form 4
2026-08-20UNITED THERAPEUTICS CorpM5,610$146.0353,472Form 4
2026-08-06UNITED THERAPEUTICS CorpS360$518.8246,800Form 4
2026-08-06UNITED THERAPEUTICS CorpS1,308$521.545,492Form 4
2026-08-06UNITED THERAPEUTICS CorpS320$522.445,172Form 4
2026-08-06UNITED THERAPEUTICS CorpM8,300$146.0353,472Form 4
2026-08-06UNITED THERAPEUTICS CorpS760$512.9252,712Form 4
2026-08-06UNITED THERAPEUTICS CorpS1,795$514.8250,917Form 4
2026-08-06UNITED THERAPEUTICS CorpS1,360$515.9349,557Form 4
2026-08-06UNITED THERAPEUTICS CorpS1,617$516.9347,940Form 4
2026-08-06UNITED THERAPEUTICS CorpS780$517.9447,160Form 4
2026-07-16UNITED THERAPEUTICS CorpS600$527.652,872Form 4
2026-07-16UNITED THERAPEUTICS CorpM8,300$146.0353,472Form 4
2026-07-16UNITED THERAPEUTICS CorpS3,279$534.2147,812Form 4
2026-07-16UNITED THERAPEUTICS CorpS861$531.9751,891Form 4
2026-07-16UNITED THERAPEUTICS CorpS80$536.8545,172Form 4
2026-07-16UNITED THERAPEUTICS CorpS1,519$534.9945,252Form 4
2026-07-16UNITED THERAPEUTICS CorpS1,041$535.8846,771Form 4
2026-07-16UNITED THERAPEUTICS CorpS120$529.8152,752Form 4
2026-07-16UNITED THERAPEUTICS CorpS800$532.9451,091Form 4
2026-07-02UNITED THERAPEUTICS CorpS258$548.7352,556Form 4
2026-07-02UNITED THERAPEUTICS CorpS990$555.8345,397Form 4
2026-07-02UNITED THERAPEUTICS CorpS225$556.3645,172Form 4
2026-07-02UNITED THERAPEUTICS CorpS658$54852,814Form 4
2026-07-02UNITED THERAPEUTICS CorpM8,300$146.0353,472Form 4
2026-07-02UNITED THERAPEUTICS CorpS2,201$553.5246,686Form 4
2026-07-02UNITED THERAPEUTICS CorpS1,818$552.6148,887Form 4
2026-07-02UNITED THERAPEUTICS CorpS1,467$551.350,705Form 4
2026-07-02UNITED THERAPEUTICS CorpS384$550.0252,172Form 4
2026-07-02UNITED THERAPEUTICS CorpS299$554.4546,387Form 4

Questions

What stock did Mahon Paul A buy or sell?

Mahon Paul A reported 59 non-derivative transactions on 6 SEC ownership filings in Q3 2026: 0 open-market purchases and 52 sales ($25.8M), across 1 company.

Is Mahon Paul A the same person as other filers with this name?

This page covers SEC CIK 1231589 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/mahon-paul-a-1231589.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.